| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Chief Commercial Ofc Imm Med | Common Stock | 297K | $5.02M | $16.91 | Nov 21, 2025 | Direct |
| Adaptive Biotechnologies Corp | Chief Commercial Ofc Imm Med | Stock Option (right to buy) | 116K | Nov 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | Nov 20, 2025 | 18 | -$5.68M | 4 | Nov 24, 2025 | Chief Commercial Ofc Imm Med |
| ADPT | Adaptive Biotechnologies Corp | Mar 4, 2025 | 4 | -$312K | 4 | Mar 6, 2025 | Chief Commercial Ofc Imm Med |
| ADPT | Adaptive Biotechnologies Corp | Mar 4, 2024 | 4 | -$101K | 4 | Mar 6, 2024 | Chief Commercial Ofc Imm Med |
| ADPT | Adaptive Biotechnologies Corp | Mar 6, 2023 | 3 | -$101K | 4 | Mar 8, 2023 | Chief Commercial Ofc Imm Med |
| ADPT | Adaptive Biotechnologies Corp | Mar 4, 2022 | 3 | -$32.1K | 4 | Mar 8, 2022 | Chief Business Development Off |